Clinical stage company developing ARC-001 – a novel, proprietary, sustained release gel which combines 3 anesthetics (lidocaine, bupivacaine, benzocaine), each with a different onset, potency, and duration of action. Targeting an efficacy profile that delivers pain relief over 5-7 days following a single dose. Phase 1 is ongoing with an expected readout in early Q1 2026.
Company Details
- Employees
- 4
- Address
- 1800 N Greene St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Dental, Pain, Therapeutics.
- HQ
- Greenville, North Carolina
- Competitors
- OligomicsTx, KASTx Ventures Inc..
Arcato Laboratories, Inc. Questions
Arcato Laboratories, Inc.'s LinkedIn profile is https://www.linkedin.com/company/arcato-laboratories-inc
Arcato Laboratories, Inc. has
4 employees.
View email and phone details for 4
employees at Arcato Laboratories, Inc..
Arcato Laboratories, Inc.'s industry is
Biotechnology Research
Arcato Laboratories, Inc.'s top competitors are
Oligomicstx,
Kastx Ventures Inc..
Arcato Laboratories, Inc.'s categories are Biotechnology Research
